Co-infection and Cancer (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-061 from the NIH Guide for Grants and Contracts. This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to investigations of co-infections with known oncogenic agents (e.g., Helicobacter pylori [H. pylori] and Epstein Barr virus [EBV]; excluding human immunodeficiency virus [HIV]) and of co-infections that engendered novel opportunities for prevention and treatment. Coinfection is defined as the occurrence of infections by two or more infectious (pathoge...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2019 Category: Research Source Type: funding

Co-infection and Cancer (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-062 from the NIH Guide for Grants and Contracts. This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to investigations of co-infections with known oncogenic agents (e.g., Helicobacter pylori [H. pylori] and Epstein Barr virus [EBV]; excluding human immunodeficiency virus [HIV]) and of co-infections that engendered novel opportunities for prevention and treatment. Coinfection is defined as the occurrence of infections by two or more infectious (pathoge...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2019 Category: Research Source Type: funding

Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-412 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research to understand and mitigate health disparities in the development, diagnosis, and treatment of diseases of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research is encouraged in the following high priority diseases: diabetes and other endocrine and metabolic diseases; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; complications of sickle cell disease within the NIDDK mission areas; kidney diseas...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2017 Category: Research Source Type: funding

Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites research to understand and mitigate health disparities in the development, diagnosis, and treatment of diseases of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research is encouraged in the following high priority diseases: diabetes and other endocrine and metabolic diseases; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; metabolic, gastrointestinal, hepatic, and renal compl...
Source: NIDDK Funding Opportunities - November 17, 2017 Category: Endocrinology Source Type: funding

Addressing Health Disparities in NIDDK Diseases (R01)
This Funding Opportunity Announcement (FOA) invites research projects to improve understanding of the causes of high priority diseases in the United States and reducing/eliminating health disparities. Research is encouraged in the following high priority diseases within the scientific mission areas of the NIDDK: diabetes; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; sickle cell disease, specifically, studies in complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; hematologic diseases, including studies in abnormal hemoglobin...
Source: NIDDK Funding Opportunities - October 19, 2016 Category: Endocrinology Source Type: funding

Addressing Health Disparities in NIDDK Diseases (R01)
Funding Opportunity Number: PA-13-183 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the ...
Source: Grants.gov - April 28, 2016 Category: Research Tags: Food and Nutrition Health Source Type: funding

American Gastroenterological Association-R. Robert & Sally Funderburg Research Award in Gastric Cancer
American Gastroenterological Association-R. Robert & Sally Funderburg Research Award in Gastric Cancer This award is made to support the research of an established investigator working on novel approaches to gastric cancer. Eligibility: Established Investigators Total Amount: $100,000 Amount per year: $50,000 Duration: Two years Deadline: Aug. 29, 2014 Start Date: Jan. 1, 2015 This award provides $50,000 per year for two years (total $100,000) to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regeneration and regu...
Source: ScanGrants feed - August 4, 2014 Category: Research Authors: American Gastroenterological Association Source Type: funding

Funderburg Research Award in Gastric Cancer
One award is made to support the research of an established investigator working on novel approaches to gastric cancer. Eligibility: Established Investigators Total Amount: $100,000 Amount per year: $50,000 Duration: 2 years Deadline: Aug. 30, 2013 Start Date: Jan. 1, 2014 This award provides $50,000 per year for two years (total $100,000) to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicob...
Source: ScanGrants feed - July 10, 2013 Category: Research Authors: American Gastroenterological Association Research Foundation Source Type: funding